Latest news and research on all cancers and treatments, updated several times a week, plus 10,000-item data base of these
My cancerousness continues to be good. My 2nd Feb CxBladder result of 0.03 was up on last month’s but still well under the ‘evidence of cancer’ level of 0.12. I am not bothering with the CEA and CA19-9 markers on a monthly basis, as these gave an erroneously high reading recently (compared with the CT scan, which didn’t find any evidence of cancer).
My other two co-morbidities are improving. My kidney marker, cystatin-C, improved. And my blood pressure remains only somewhat elevated whilst I am reducing the hypertension drugs I am taking.
"They seem to be working quite well for multiple different cancers," Brahmer says, including kidney cancer, bladder cancer, head and neck cancers, ...
For women with bladder cancer, for instance, much of the information available is about men, who are three times more likely to be diagnosed.
Speaking today at the Keystone Symposia on Tumor Immunology in Banff, Canada, Arthur Machlenkin, PhD, Head of Immunology Group at ...
... and survival, including enabling them to resist immunosuppressive mechanisms in tumors that can limit the efficacy of cancer immunotherapy.
NeuVax™ is a first-in-class, HER2-directed cancer immunotherapy under evaluation to prevent breastcancer recurrence after standard of care ...
Wei Dong Han, MD, PhD, head of PLAGH's Biotherapy Department, is a renowned key opinion leader in the cancer immunotherapy field. Professor ...
NPR News on Twitter: "Immunotherapy pulls off cancer's invisibility cloak by blocking the switch ...
Immunotherapy pulls off cancer's invisibility cloak by blocking the switch that turns it on. http://n.pr/1vdrnnxpic.twitter.com/ejJ69HnVzs. 0 replies 135 ...
Researchers from the Oncology Department of Tianjin Medical University Cancer Hospital in China recently published a study in Advanced Functional ...
Pancreatic cancer has extremely low survival rates as the majority of patients ... Ms Alex Ford, Chief Executive of Pancreatic Cancer UK, said: “We are ...
Celgene Announces Positive Recommendation by Scottish Medicines Consortium (SMC) for ... -MarketWatch
He added, "The potential risks of pancreatitis and pancreatic cancer with GLP-1–based therapies are far outweighed by the proven [benefits] and ...
Lung cancer is the most common and the deadliest type of cancer ... blood, breast and pancreatic cancer, while sparing normal cells and tissues.
Modeling Pancreatic Tumor Motion Using 4-Dimensional Computed ... M. et al, Patterns of recurrence after curative resection of pancreatic cancer, ...
Science Daily Cancer News
Investigators have discovered inherited genetic variations that are associated with rapid hearing loss in young cancer patients treated with the drug cisplatin.
For the first time, cancer researchers have traced the origins of colorectal cancer cells, finding important clues to why tumor cells become 'good' or 'bad,' with the potential of stopping them before they start.
Applying lessons learned from autism to brain cancer, researchers have discovered why elevated levels of the protein NHE9 add to the lethality of the most common and aggressive form of brain cancer, glioblastoma. Their discovery suggests that drugs designed to target NHE9 could help to successfully fight the deadly disease.
Researchers have developed a novel 3-D vaccine that could provide a more effective way to harness the immune system to fight cancer as well as infectious diseases. The vaccine spontaneously assembles into a scaffold once injected under the skin and is capable of recruiting, housing, and manipulating immune cells to generate a powerful immune response. The vaccine was recently found to be effective in delaying tumor growth in mice.
Only 1.3 percent of cancers diagnosed between 2004 and 2010 were cancers of the ovary, but fewer than half of these women survived for five years or more. Researchers have now studied a combination therapy developed to help women with ovarian cancer.
Researchers have designed and developed hybrid gold-silica nanoparticles, which are turning out to be genuine therapeutic “Swiss Army knives”. Tested in mice and on cultured human cells, they make it possible to combine two forms of tumor treatment and three imaging techniques. They notably have a greater drug loading and delivery capacity than carriers currently on the market, which opens interesting perspectives for cancer research.
Arsenic is the biggest public-health problem for water in the United States -- yet we pay far less attention to it than we do to lesser problems. Private wells present continuing risks. Even low doses of arsenic may reduce intelligence in children. There are also well-documented risks of cancer, heart disease, and reduced lung function.
Tambahkan Komentar